‘Breakthrough’ Therapies: Information Requests A Sign Of Workload Problem?

FDA on average sent about 20 more information requests during breakthrough product reviews than others in the Program, according to interim assessment of the PDUFA V review system. Assessment could support higher funding for breakthrough program in next user fee round.